Seres Therapeutics Inc. (MCRB)
NASDAQ: MCRB
· Real-Time Price · USD
7.00
0.00 (0.00%)
At close: Jun 03, 2025, 3:59 PM
7.31
4.43%
After-hours: Jun 03, 2025, 06:06 PM EDT
0.00% (1D)
Bid | 6.7 |
Market Cap | 61.13M |
Revenue (ttm) | n/a |
Net Income (ttm) | 72.95M |
EPS (ttm) | -7.95 |
PE Ratio (ttm) | -0.88 |
Forward PE | -0.87 |
Analyst | Hold |
Ask | 7.52 |
Volume | 127,977 |
Avg. Volume (20D) | 89,496 |
Open | 7.10 |
Previous Close | 7.00 |
Day's Range | 6.98 - 7.41 |
52-Week Range | 6.53 - 30.60 |
Beta | 2.88 |
About MCRB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MCRB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MCRB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-16.04%
Seres Therapeutics shares are trading lower after ...
Unlock content with
Pro Subscription
5 months ago
+3.83%
Seres Therapeutics shares are trading higher after the company announced that SER-155 received FDA breakthrough therapy designation for its bloodstream infection reduction.

2 months ago · seekingalpha.com
Seres Therapeutics, Inc. (MCRB) Q4 2024 Earnings Call TranscriptSeres Therapeutics, Inc. (NASDAQ:MCRB ) Q4 2024 Earnings Conference Call March 13, 2025 8:30 AM ET Company Participants Carlo Tanzi - Kendall Investor Relations Eric Shaff - President and Chief Execut...